08/11/2025
From JAMA: inhibitors reduced CKD progression, acute kidney injury, and kidney failure regardless of baseline eGFR or albuminuria levels. Results support routine use in all stages of CKD, including stage 4 CKD and minimal albuminuria.
https://ja.ma/3JNY9OC